These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 7806579)

  • 1. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
    Miettinen PJ; Ebner R; Lopez AR; Derynck R
    J Cell Biol; 1994 Dec; 127(6 Pt 2):2021-36. PubMed ID: 7806579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
    Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
    J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
    Maeda M; Shintani Y; Wheelock MJ; Johnson KR
    J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
    Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
    Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.
    Joseph H; Gorska AE; Sohn P; Moses HL; Serra R
    Mol Biol Cell; 1999 Apr; 10(4):1221-34. PubMed ID: 10198068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH; Derynck R
    EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
    Bhowmick NA; Zent R; Ghiassi M; McDonnell M; Moses HL
    J Biol Chem; 2001 Dec; 276(50):46707-13. PubMed ID: 11590169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation.
    Kondo M; Cubillo E; Tobiume K; Shirakihara T; Fukuda N; Suzuki H; Shimizu K; Takehara K; Cano A; Saitoh M; Miyazono K
    Cell Death Differ; 2004 Oct; 11(10):1092-101. PubMed ID: 15181457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
    Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
    Park CY; Kim DK; Sheen YY
    Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
    Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
    J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
    Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
    Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
    Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
    Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor.
    Filvaroff EH; Ebner R; Derynck R
    Development; 1994 May; 120(5):1085-95. PubMed ID: 8026322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory expression of genes related to metastasis by TGF-beta and activin A in B16 murine melanoma cells.
    Murakami M; Suzuki M; Nishino Y; Funaba M
    Mol Biol Rep; 2010 Mar; 37(3):1279-86. PubMed ID: 19288218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
    Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
    Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An emerging complexity of receptors for transforming growth factor-beta.
    Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
    Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
    Mercado-Pimentel ME; Runyan RB
    Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.